Clin2
NCT07433179Likely a fitRecruiting

Testing SEP-479 in healthy adults

Healthy Volunteers

This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
150 people
Ages
21 years to 60 years
Study type
Interventional

Who can take part

  • Age between 21 and 60 years old
  • Body mass index (BMI) between 18 and 32
  • In general good health
  • Not currently enrolled in another clinical trial

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07415304Not yet recruiting· Phase 1
Safety study of ISM4808 in healthy volunteers

This trial tests the safety of a new drug called ISM4808 in healthy adults. It helps doctors see how the drug affects the body and if it causes any side effects before moving to larger studies.

NCT07527221Recruiting· Phase 1
Safety study of ZE74-0282 in healthy adults

This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.

Randwick, New South Wales
NCT07658638Recruiting· Phase 1
Safety study of TESP-0401 in healthy volunteers

This study tests a new oral medication, TESP-0401, in healthy volunteers to check its safety, how the body processes it, and any side effects. It is a first-in-human trial, so participants help determine if the drug is safe enough for future studies.

Charlestown, Suite 301, 99 Pacific Highway,NSW
NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT06995326Not yet recruiting· Phase 1
Study of an experimental drug SGB-3383 in healthy volunteers

This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.

NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.